Skip to content

A Survey of Turkish Pediatric Physical Therapists

Use of Tools for Early Detection of Cerebral Palsy: A Survey of Turkish Pediatric Physical Therapists

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07180017
Enrollment
105
Registered
2025-09-18
Start date
2023-03-01
Completion date
2024-04-30
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy (CP), Detection, Pediatric Physiotherapy, Survey

Brief summary

CP encompasses a group of persistent disorders of movement and posture development resulting from injury to the developing brain. Thanks to preventive measures and advances in obstetric and neonatal care, the incidence and severity of CP are currently decreasing in some countries, and the use of early diagnosis guidelines or protocols in follow-up units highlights the potential for faster recovery. A 2017 clinical review of early diagnosis tools, published by a group of international experts with best practice recommendations, called for earlier diagnosis through timely use of recommended tools. The diagnosis of CP is typically made by a physician between 12 and 24 months of age, but in some cases, it is delayed until 42 months. Early identification of a high risk of CP relies on a combination of a detailed patient history, developmental assessment, a structured and validated neurological examination or neuromotor assessment, and brain imaging studies. Conversely, the accurate and early use of key tools for early diagnosis can allow for much earlier detection of CP in infants younger than or older than 5 months.According to international guidelines, infants at high risk of CP should be monitored. This monitoring should be conducted by an interdisciplinary team, including a neonatologist, pediatrician, pediatric neurologist, pediatric physiotherapist, speech-language-swallowing therapist, and special education specialist. Pediatric physiotherapists are a crucial part of this team for developmental follow-up and rehabilitation. Therefore, it is important that pediatric physiotherapists in our country have sufficient awareness in this field, are equipped with various training programs, and reach international standards. This allows them to provide early guidance to families at risk of CP, facilitate early diagnosis of CP, and initiate treatment.The aim of this study was to evaluate the use of early diagnostic assessment tools in pediatric physiotherapy practice in Turkey for infants aged 0-2 years at risk for cerebral palsy (CP). Best practice guidelines worldwide recommend the timely use of key assessment tools to reduce the age at which CP is diagnosed. In this context, a digital survey administered to pediatric physiotherapists in Spain, translated into Turkish with the necessary permissions, will be used to determine the awareness levels of physiotherapists in Turkey.

Interventions

None listed

Sponsors

Kahramanmaras Sutcu Imam University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* All literate pediatric physiotherapists between the ages of 25-50 working in different provinces in Turkey

Exclusion criteria

* Physiotherapists with no experience in pediatric physiotherapy

Design outcomes

Primary

MeasureTime frameDescription
Digital survey for pediatric physiotherapists(PTs)DAY1A purpose-built digital survey consisting of 45 multiple-choice questions with five thematic sections. The survey used in this context will be a survey administered digitally to pediatric physiotherapists in Spain, translated into Turkish with the necessary permissions. This survey will be administered via Google Forms.

Secondary

MeasureTime frameDescription
Demographic InformationDAY1Sosyodemographic information of PTs will be recorded.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026